When it was passed in 1992, no one thought to mandate how hospitals and clinics would spend the deep discounts they receive on prescription drugs.

THMA announces its 2026 Cardiovascular and Oncology Executive Convenings, bringing together C-suite leaders from major health systems and life sciences companies to address supply-chain disruption, ...

A top Senate Republican say passing Medicaid work requirements will be an uphill battle. Former Senate President Don Gaetz ...

The Washington state House Appropriations Committee has advanced a bill concerning a federal drug pricing program known as ...

A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state.  | A Minnesota analysis of providers' reported ...

Rhode Island's attorney general is embroiled in a legal battle with Big Pharma over a state law that aims to protect hospital ...

A Health Department report highlights big dollars that could be better targeted, some say, so patients and safety net ...

Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in revenue in 2024.

The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...

Drug pricing 2026 forces are reshaping pharmacy economics through Medicare negotiations, FTC actions, and federal pricing models.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...